Clarkston Capital Partners LLC boosted its stake in Clarivate PLC (NYSE:CLVT - Free Report) by 5.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 74,527,914 shares of the company's stock after buying an additional 3,794,083 shares during the quarter. Clarivate makes up about 5.8% of Clarkston Capital Partners LLC's holdings, making the stock its 2nd biggest position. Clarkston Capital Partners LLC owned approximately 10.91% of Clarivate worth $292,895,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bessemer Group Inc. purchased a new stake in Clarivate in the 1st quarter worth approximately $30,000. Millstone Evans Group LLC lifted its position in Clarivate by 156.6% in the 1st quarter. Millstone Evans Group LLC now owns 7,545 shares of the company's stock worth $30,000 after buying an additional 4,605 shares in the last quarter. MQS Management LLC purchased a new stake in Clarivate in the 1st quarter worth approximately $44,000. Essex Financial Services Inc. purchased a new stake in Clarivate in the 1st quarter worth approximately $45,000. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in Clarivate in the 4th quarter worth approximately $56,000. Hedge funds and other institutional investors own 85.72% of the company's stock.
Insider Transactions at Clarivate
In related news, insider James Gordon Samson sold 100,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total value of $453,000.00. Following the transaction, the insider directly owned 1,271,103 shares in the company, valued at approximately $5,758,096.59. This trade represents a 7.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 23.18% of the company's stock.
Clarivate Stock Performance
Shares of CLVT opened at $4.4550 on Thursday. The company's fifty day moving average is $4.22 and its 200-day moving average is $4.19. Clarivate PLC has a 12 month low of $3.04 and a 12 month high of $7.15. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of -7.19 and a beta of 1.40. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.90.
Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.18 EPS for the quarter, hitting the consensus estimate of $0.18. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The company had revenue of $621.40 million for the quarter, compared to analyst estimates of $587.17 million. During the same quarter in the prior year, the business posted $0.20 EPS. Clarivate's quarterly revenue was down 4.4% on a year-over-year basis. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. Equities analysts expect that Clarivate PLC will post 0.63 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research firms have issued reports on CLVT. Jefferies Financial Group began coverage on shares of Clarivate in a research report on Friday, July 18th. They issued a "hold" rating and a $4.50 target price for the company. Wall Street Zen lowered shares of Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st. Three investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and a consensus price target of $4.83.
Get Our Latest Stock Analysis on CLVT
Clarivate Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate PLC (NYSE:CLVT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access